TET2 and cancer: To further investigate whether the RCMS dCasRx-Tet2 CD editor could induce a decrease in m5C level and impact the invasive and metastatic phenotype in cancer cells, we transduced HepG2 cells with dCasRx-Tet2 CD with gRNA 0 nt or nontarget gRNA using a lentivirus system.